Sponsored
The Analysis of Sermonix Pharmaceuticals, Inc.'s Holdings & P&L
Currently, Sermonix Pharmaceuticals, Inc. holds 1 types of securities in its portfolio with a total value $37.1M. In the most recent quarter, they have increased their positions in ATHA (+5.5M shares, valued at $37.1M); initiated new positions in ATHA (+5.5M shares, valued at $37.1M).
Top Holding Treemap
Sponsored
Stock Holdings
TickerCompany NameSharesShares β³%Event DateReport DateHistory
New
Shares5.5M
Event2026-08-24
Filed2026-08-31
Call Option Holdings
No call option holdings data available
No call option holdings data available
Put Option Holdings
No put option holdings data available
No put option holdings data available